Skip to main content
Clinical Trials/NCT04791072
NCT04791072
Unknown
N/A

Effectiveness of Pulmonary Rehabilitation With Tele-coaching in Patients With COVID-19

Izmir Katip Celebi University0 sites36 target enrollmentMarch 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Covid19
Sponsor
Izmir Katip Celebi University
Enrollment
36
Primary Endpoint
Exercise Capacity
Last Updated
5 years ago

Overview

Brief Summary

Respiratory exercise training and aerobic exercise training will be given to patients who have been hospitalized in intensive care due to COVID 19 and underwent IMV, who were hospitalized in the service and underwent NIMV or high-flow oxygen inhalation, and whose respiratory symptoms persist after discharge. The patients in the study group will be called by phone once a week and a motivating conversation will be made. No control will be made to the control group. Before and after the training, 6-minute walking test, MRC dyspnea scale, SGRQ quality of life questionnaire and hospital anxiety depression scale will be applied.

Detailed Description

Some of the patients with COVID 19 pneumonia still have respiratory symptoms despite being treated. It has been reported that pulmonary rehabilitation programs applied in various models and in a small number to relieve or reduce these symptoms reduce dyspnea, increase exercise capacity and improve quality of life. There is no study reporting the results of a pulmonary rehabilitation program applied to COVID 19 patients in our country. The main purpose of this study is to determine the efficacy of pulmonary rehabilitation applied by telecoach to patients with severe COVID 19 pneumonia or persistent respiratory symptoms. Secondly, it is aimed to present the data of Turkish society to the literature. In accordance with this purpose investigators planed a randomised control clinical study. In our study respiratory exercise training and aerobic exercise training will be given to patients who have been hospitalized in intensive care due to COVID 19 and underwent IMV, who were hospitalized in the service and underwent NIMV or high-flow oxygen inhalation, and whose respiratory symptoms persist after discharge. The patients in the study group will be called by phone once a week and a motivating conversation will be made. No control will be made to the control group. Before and after the training, 6-minute walking test, MRC dyspnea scale, SGRQ quality of life questionnaire and hospital anxiety depression scale will be applied.

Registry
clinicaltrials.gov
Start Date
March 1, 2021
End Date
March 1, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Izmir Katip Celebi University
Responsible Party
Principal Investigator
Principal Investigator

Ilknur Naz

Assoc. Prof.

Izmir Katip Celebi University

Eligibility Criteria

Inclusion Criteria

  • Being treated in intensive care unit due to COVID-19 pneumonia,
  • Receiving IMV, NIMV, or high-flow oxygen therapy
  • Patients whose respiratory symptoms persist despite discharge

Exclusion Criteria

  • Patients with PCR test +
  • Patients without any complaints.
  • Patients who are hospitalized and discharged within 10 days
  • Patients with orthopedic, neurological, cognitive problems

Outcomes

Primary Outcomes

Exercise Capacity

Time Frame: Change from baseline six minute walk distance at 8 week

Six Minute- walk test

Secondary Outcomes

  • Quality of Life Assessment(Change from baseline quality of life at 8 week)
  • Dyspnea Assessment(Change from baseline dyspnea at 8 week)
  • Anxiety and Depression(Change from baseline anxiety and depression at 8 week)

Similar Trials